Structure-activity relationships for a novel series of dopamine D2-like receptor ligands based on N-substituted 3-aryl-8-azabicyclo[3.2.1]octan-3-ol.
Discovering dopamine D2-like receptor subtype-selective ligands has been a focus of significant investigation. The D2R-selective antagonist 3-[4-(4-chlorophenyl)-4-hydroxypiperidinyl]methylindole (1, L741,626; K(i)(D2R/D3R) = 11.2:163 nM) has previously provided a lead template for chemical modification. Herein, analogues have been synthesized where the piperidine was replaced by a tropane ring that reversed the selectivity seen in the parent compound, in human hD2(L)R- or hD3R-transfected HEK 293 cells (31, K(i)(D2R/D3R) = 33.4:15.5 nM). Further exploration of both N-substituted and aryl ring-substituted analogues resulted in the discovery of several high affinity D2R/D3R ligands with 3-benzofurylmethyl-substituents (e.g., 45, K(i)(D2R/D3R) = 1.7:0.34 nM) that induced high affinity not achieved in similarly N-substituted piperidine analogues and significantly (470-fold) improved D3R binding affinity compared to the parent ligand 1. X-ray crystallographic data revealed a distinctive spatial arrangement of pharmacophoric elements in the piperidinol vs tropine analogues, providing clues for the diversity in SAR at the D2 and D3 receptor subtypes.
Paul
Noel M
NM
Medicinal Chemistry Section, National Institute on Drug Abuses, Intramural Research Program, National Institutes of Health, Baltimore, Maryland 21224, USA.
Taylor
Michelle
M
Kumar
Rakesh
R
Deschamps
Jeffrey R
JR
Luedtke
Robert R
RR
Newman
Amy Hauck
AH
D053961:Azabicyclo Compounds / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D001665:Binding Sites; D018360:Crystallography, X-Ray; D008024:Ligands; D008958:Models, Molecular; D015394:Molecular Structure; D017448:Receptors, Dopamine D2 / Q000737:chemistry / Q000187:drug effects*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
D053961:Azabicyclo Compounds; D008024:Ligands; D017448:Receptors, Dopamine D2
Bioorg Med Chem Lett. 2004 Jan 19;14(2):515-8
14698193
J Med Chem. 2005 Jun 2;48(11):3663-79
15916415
Nature. 1990 Sep 13;347(6289):146-51
1975644
Annu Rev Pharmacol Toxicol. 1993;33:281-307
8494342
Bioorg Med Chem Lett. 2004 Dec 6;14(23):5739-42
15501032
Nat Neurosci. 2006 Aug;9(8):1050-6
16829955
CNS Drug Rev. 2007 Summer;13(2):240-59
17627675
Drug Discov Today. 2006 Jun;11(11-12):481-93
16713899
Nat Rev Drug Discov. 2004 Apr;3(4):353-9
15060530
J Med Chem. 2007 Feb 22;50(4):865-76
17300168
Bioorg Med Chem Lett. 2003 Nov 3;13(21):3779-82
14552778
J Neurochem. 2006 Nov;99(4):1033-48
17054441
Expert Opin Investig Drugs. 2007 Jan;16(1):45-57
17155853
J Med Chem. 1996 May 10;39(10):1941-2
8642550
J Pharmacol Exp Ther. 2008 Feb;324(2):600-11
18024787
J Pharmacol Exp Ther. 2007 Mar;320(3):1268-78
17170312
J Med Chem. 2005 Oct 20;48(21):6523-43
16220969
Arch Neurol. 2007 Nov;64(11):1575-9
17998440
J Pharmacol Exp Ther. 2008 Feb;324(2):587-99
18024789
Addict Biol. 2007 Jun;12(2):133-51
17508985
J Clin Psychiatry. 2007;68 Suppl 14:20-6
18284274
Eur J Pharmacol. 2000 Mar 10;391(1-2):63-73
10720636
Methods Enzymol. 1998;296:331-46
9779459
Am J Psychiatry. 1999 Sep;156(9):1440-3
10484959
Bioorg Med Chem Lett. 2007 Feb 1;17(3):745-9
17095222
Neuropsychopharmacology. 2004 Jun;29(6):1190-202
15010698
Bioorg Med Chem Lett. 2003 Jul 7;13(13):2179-83
12798330
Mol Pharmacol. 2001 Jul;60(1):1-19
11408595
J Med Chem. 2005 Feb 10;48(3):839-48
15689168
J Pharmacol Exp Ther. 2007 May;321(2):573-82
17272677
J Med Chem. 2004 Jan 29;47(3):497-508
14736232
Curr Opin Investig Drugs. 2008 Jan;9(1):37-46
18183530
J Med Chem. 2001 Sep 13;44(19):3175-86
11543687
J Pharmacol Exp Ther. 2008 Mar;324(3):1212-26
18096759
Pharmacol Biochem Behav. 2005 May;81(1):190-7
15894078
Bioorg Med Chem Lett. 2007 Jan 15;17(2):400-5
17084080
J Med Chem. 2007 Aug 23;50(17):4135-46
17672446
J Psychopharmacol. 1999 Dec;13(4):337-45
10667609
Mol Psychiatry. 2004 Jun;9(6):557-69
15098002
Bioorg Med Chem Lett. 2007 Oct 1;17(19):5340-4
17720494
J Med Chem. 2001 Dec 6;44(25):4453-61
11728190
Pharmacol Ther. 2006 Oct;112(1):281-333
16905195
J Med Chem. 1988 Feb;31(2):433-44
3339613
Brain Res Brain Res Rev. 2005 Jul;49(1):77-105
15960988
Bioorg Med Chem. 2006 Feb 1;14(3):815-25
16288878